| Natera, Inc. Common Stock | $56.0b | $318.40 | -1.1% | 1.2M | |
| Illumina Inc | $36.0b | $207.76 | -1.2% | 938.2K | |
| Labcorp Holdings Inc. | $28.7b | $370.36 | -0.5% | 358.2K | |
| QIAGEN N.V. | $10.4b | $49.90 | -0.4% | 1.5M | |
| Bio-Rad Laboratories, Inc.Class A | $10.0b | $366.26 | -1.1% | 218.0K | |
| 10x Genomics, Inc. Class A Common Stock | $8.5b | $57.56 | -1.6% | 1.8M | |
| BillionToOne, Inc. Class A Common Stock | $5.2b | $108.75 | -5.0% | 609.2K | |
| CareDx, Inc. | $4.6b | $78.26 | -2.4% | 641.1K | |
| Veracyte, Inc. | $4.0b | $23.71 | -1.3% | 1.6M | |
| NeoGenomics, Inc. | $2.2b | $16.02 | -3.2% | 1.9M | |
| GeneDx Holdings Corp. Class A Common Stock | $2.0b | $52.41 | +0.9% | 1.0M | |
| Personalis, Inc. Common Stock | $1.7b | $15.71 | -1.0% | 2.5M | |
| Azenta, Inc. | $1.6b | $45.62 | +4.1% | 770.0K | |
| Opko Health Inc. | $1.3b | $1.67 | +0.9% | 1.9M | |
| Pacific Biosciences of California, Inc. | $0.8b | $1.93 | -0.8% | 6.6M | |
| Mesa Laboratories Inc | $0.7b | $136.03 | +3.1% | 73.5K | |
| Myriad Genetics Inc | $0.6b | $5.60 | -0.7% | 767.9K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $24.65 | -0.8% | 211.8K | |
| Prenetics Global Limited Class A Ordinary Share | $315.9m | $16.80 | -0.8% | 133.9K | |
| Insight Molecular Diagnostics Inc. Common Stock | $89.7m | $2.28 | -8.7% | 160.6K | |
| Quantum Cyber N.V. Ordinary Shares | $60.8m | $0.71 | +11.4% | 501.6K | |
| ALPS Group Inc Ordinary Share | $50.7m | $1.19 | +1.3% | 28.8K | |
| Bionano Genomics, Inc. Common Stock | $16.8m | $1.01 | -3.4% | 556.0K | |
| BioNexus Gene Lab Corp Common stock | $2.8m | $0.84 | 0.0% | 865 |